Molecular mechanisms regulating NLRP3 inflammasome activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular mechanisms regulating NLRP3 inflammasome activation

Published:2015-11-09 Issue:2 Volume:13 Page:148-159
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Jo Eun-Kyeong,Kim Jin Kyung,Shin Dong-Min,Sasakawa Chihiro

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/cmi201595.pdf

Reference136 articles.

1. Davis BK, Wen H, Ting JP . The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2010; 29: 707–735.

2. De Nardo D, Latz E . NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 2011; 32: 373–379.

3. Martinon F, Burns K, Tschopp J . The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417–426.

4. Lamkanfi M . Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011; 11: 213–220.

5. Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P et al. Differential expression of NLRP3 among hematopoietic cells. J Immunol 2011; 186: 2529–2534.

Cited by 1032 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury;European Journal of Medicinal Chemistry;2024-11

2. MIF aggravates experimental autoimmune prostatitis through activation of the NLRP3 inflammasome via the PI3K/AKT pathway;International Immunopharmacology;2024-11

3. Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib);Life Sciences;2024-10

4. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10

5. Small molecule innate immune modulators in cancer therapy;Frontiers in Immunology;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3